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Introduction
PTEN-induced putative kinase (PINK1), a mitochondrial ser-
ine kinase, and Parkin, a cytosolic E3-ubiqutin ligase, function 
cooperatively to degrade damaged mitochondria by the auto-
phagic machinery (mitophagy). Mutations in PINK1 and Par-
kin are a cause of early onset familial Parkinson disease (PD; 
Schapira, 2008), and Parkin deficiency is implicated in sporadic 
PD (Chung et al., 2004), thus suggesting direct connectiv-
ity between mitochondrial homeostasis and PD pathogenesis. 
Understanding the mechanism of PINK1-Parkin mitophagy 
may facilitate the development of therapeutic strategies for PD 
(Schapira et al., 2014).
Mitophagy has three requisite steps: the activation of 
Parkin E3-ubiquitin ligase activity at the outer mitochondrial 
membrane (OMM; Narendra et al., 2008, 2010; Tanaka et al., 
2010), dynamin-related protein 1 (DRP1)–catalyzed fission of 
the damaged mitochondria (Twig et al., 2008; Narendra et al., 
2010), and the recruitment of the autophagy receptor NDP52 
or optineurin to the OMM (Lazarou et al., 2015). The first step 
is well established: PINK1 normally resides in the inner mi-
tochondrial membrane, but when damage dissipates the mito-
chondrial membrane potential (mΔΨ), protein import ceases and 
PINK1 instead accumulates in the OMM (Narendra et al., 2010; 
Matsuda et al., 2010; Vives-Bauza et al., 2010) via association 
with TOM7 inthe TOM complex (Hasson et al., 2013). Here, 
PINK1 phosphorylates Parkin (Kondapalli et al., 2012; Shi-
ba-Fukushima et al., 2012) and ubiquitin (Koyano et al., 2014; 
Kane et al., 2014) to coactivate Parkin (Wauer et al., 2015), and 
the ubiquitylation of numerous OMM proteins. OMM ubiq-
uitin tags signal whole-organelle engulfment and degradation 
by autophagy (Narendra et al., 2010). OMM-bound PINK1 
also mediates the recruitment of NDP52 and optineurin, inde-
pendently of Parkin, which in turn direct the autophagy factors 
ULK1 and DFCP1 to damaged mitochondria (Lazarou et al., 
2015). Fission is required to generate mitochondrial particles 
sufficiently small to be engulfed by the autophagosome. How-
ever, we propose that the established mechanism explaining the 
fission step is ambiguous.
Normally, OMM-bound A-kinase anchoring protein 1 
(AKAP1) binds tetrameric (two regulatory and catalytic sub-
units) protein kinase A (PKA), via a conserved regulatory sub-
unit binding grove. Here, PKA phospho-inhibits DRP1 at serine 
637 to diminish fission (Chang and Blackstone, 2007; Cribbs 
and Strack, 2007; Cereghetti et al., 2008). PKA is catalytically 
active, even though the catalytic and regulatory subunits are 
associated, because local PKA substrates are orientated into a 
phosphorylatable configuration by AKAP1 (Smith et al., 2013). 
Thereby mitochondria form elongated fused structures in many 
cell types as rates of fusion exceed fission. In the majority of 
studies mitophagy and fission are stimulated by systemically de-
polarizing mitochondria (using toxins such as carbonyl cyanide 
m-chlorophenyl hydrazone [CCCP] or antimycin A combined 
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with oligomycin), and fission is driven by the increased cy-
tosolic calcium (released from depolarized mitochondria), 
which activates DRP1 serine 637 dephosphorylation by calci-
neurin (Chang and Blackstone, 2007; Cribbs and Strack, 2007; 
Cereghetti et al., 2008). However, we and others (Schon and 
Przedborski, 2011) contend that this level of chemically in-
duced mitochondrial damage, including the related cytosolic 
calcium changes, exceeds physiological limits and is thus prob-
ably not mechanistically relevant to the fundamental mitophagy 
pathway. For instance, it is difficult to rationalize how damaged 
sections of the mitochondrial reticulum would be selectively 
distinguished for fission during basal mitophagy; calcium that 
is released from depolarized/damaged regions of the reticulum 
will rapidly diffuse throughout the cytosol (according to the dif-
fusion coefficient) and also be strongly buffered by surround-
ing ER and polarized mitochondria. Thereby calcium cannot 
function as a local damage signal that is relayed to promote 
fission. Here, we provide a mechanistic framework to explain 
“selective fission” and unravel how DRP1 is targeted to recog-
nize damaged mitochondria.
Results and discussion
Because PINK1 recruits Parkin and autophagy receptors and 
factors to damaged mitochondria, we reasoned PINK1 may 
also promote fission. To clearly and conclusively determine if 
PINK1 promotes fission independently of calcium-calcineurin, 
we used a regulated heterodimerization system to target ec-
topic PINK1 to the OMM while maintaining mΔΨ. Previous 
studies have used this experimental system to show OMM- 
localized PINK1 recruits Parkin, optineurin, and NDP52 to the 
OMM even if mitochondria remain polarized (Lazarou et al., 
2012, 2015). Cells were cotransfected with wild-type (WT) or 
kinase-dead (KD) PINK1Δ110-YFP (lacking the mitochondrial 
localization sequence and integral domain) and the integral 
OMM protein Fis1 genetically fused with the FKBP and FRB 
domains, respectively. FKBP and FRB dimerize in the presence 
of exogenous rapalog. In transfected SH-SY5Y cells (express-
ing endogenous PINK1/Parkin; Fig. S1, A–C), rapalog treat-
ment redistributed PINK1 to TOM20-stained mitochondria and 
triggered kinase-dependent mitochondrial fission (Fig. 1, A–D). 
Interestingly, WT PINK1Δ110-YFP-FKBP pro-fission activity 
was conserved in two rapalog-treated PD-Parkin–deficient fi-
broblast cultures (Fig. 1, E–H; and Fig. S1, N and O) lacking 
Parkin and associated MFN1 ubiquitylation activity (Fig.  1  I 
and Fig. S1 D) but expressing PINK1 (Fig. S1 E). Rapalog did 
not indirectly affect morphology in WT or KD PINK1Δ110-
YFP-FKBP–negative cells (Fig. 1, A, B, E, and F; and Fig. S1, 
N and O), change cytosolic calcium levels (Fig. S1, G–K), de-
polarize mΔΨ (Fig. S1, L and M), or induce MFN1 ubiquityla-
tion (Fig. S1 F). OMM-bound WT PINK1 is a powerful fission 
activator independent of Parkin activity and calcium.
The OMM-associated AKAP1–PKA axis is a core phys-
iological mitochondrial morphology regulator by controlling 
DRP1 phosphorylation at serine 637 (Newhall et al., 2006; 
Carlucci et al., 2008; Dickey and Strack, 2011; Kim et al., 
2011; Pfluger et al., 2015). Modulating AKAP1-PKA activity 
is sufficient to hyperfuse or fragment the mitochondrial retic-
ulum without affecting other components of the fission–fusion 
machinery; DRP1 serine 637 phosphomimic mutagenesis ro-
bustly impairs fission, whereas serine-to-alanine mutagenesis 
confers notable pro-fission activity (Cribbs and Strack, 2007; 
Cereghetti et al., 2008; Merrill et al., 2011), as does depleting 
AKAP1 levels (by preventing DRP1 serine 637 phosphoryla-
tion; Fig. S2, A–D; Carlucci et al., 2008; Merrill et al., 2011). 
During hypoxia, AKAP1 is degraded by the E3-ubiquitin ligase 
Siah2 (Carlucci et al., 2008; Kim et al., 2011). In view of this, 
we considered that OMM-PINK1 could activate Parkin or an-
other E3-ligase to degrade AKAP1 and drive fission. Instead, 
AKAP1 levels maintained in CCCP-treated SH-SY5Y cells, 
whereas the endogenous Parkin substrate MFN1 was mark-
edly degraded, decreasing by 40% and 90% after 1- and 4-h 
CCCP treatment, respectively (Fig. 2, A and B). Both AKAP1 
and MFN1 maintained in CCCP-treated HeLa cells (Fig. 2, A 
and B) expressing PINK1 but devoid of Parkin/CCCP-induced 
MFN1 ubiquitylation (Fig. S1, A–C). Eventual AKAP1 loss in 
SH-SY5Y cells correlated with mitochondrial proteins pro-
hibitin-1, complex IV subunit II (cx4-II), and reduced citrate 
synthase activity (Fig. 2, A–C), thus reflecting bulk mitophagy. 
Overexpressing Parkin (Fig. S1 B) amplified CCCP-dependent 
AKAP1 turnover similarly to other mitophagy marker proteins 
(Fig. 2, D and E). AKAP1 was not degraded in CCCP-treated 
primary human fibroblasts used in this study (Fig. S2, E–I). Ejec-
tion of AKAP1 from the OMM could explain PINK1-activated 
fission by displacing PKA and thus preventing DRP1 serine 637 
phosphorylation. However, AKAP1 retained in mitochondrial 
fractions isolated from depolarized SH-SY5Y (Fig.  2, F and 
G) and HeLa cells (Fig. 3, A and B). AKAP1 also continued 
to strongly colocalize with TOM20-stained mitochondria after 
mΔΨ dissipation in SH-SY5Y cells (Fig. 2 H); TOM20-AKAP1 
Pearson coefficients were unaffected during 4-h depolarization. 
Furthermore, the loss of AKAP1 via mitophagy is absolutely 
consistent with AKAP1 retention in the OMM of damaged mi-
tochondria (Fig. 2, A, B, D, and E); i.e., AKAP1 does not es-
cape bulk organelle turnover. Interestingly, we found that PKA 
catalytic subunit (Catβ) levels diminished progressively in mi-
tochondrial fractions isolated from CCCP-treated HeLa (Fig. 3, 
A and B) and SH-SY5Y cells (Fig. S2, J and K), decreasing 
by 50–60% and 65–80% in both cell types after 1- and 2-h 
CCCP treatment, respectively. These findings indicate that the 
AKAP1–PKA axis is somehow disrupted after mitochondrial 
depolarization and PINK1 activation, regardless of Parkin.
Next, a series of coimmunoprecipitation (CoIP) experi-
ments revealed the composition of the AKAP1-PKA signal-
ing apparatus and were used to further unravel modulation of 
AKAP1-PKA after mΔΨ dissipation. AKAP1 exclusively pre-
cipitated PKA regulatory subunit II α (RIIα) and Catβ in both 
HeLa (Fig. 3 C) and SH-SY5Y (Fig. S3 A) cells. AKAP1 was 
also precipitated in the “reverse” RIIα and Catβ immunopre-
cipitations (IPs; Fig. S3, B–I). Our findings reveal regulatory 
and catalytic PKA isoform discrimination and AKAP1–PKA 
conservation. In contrast, RIIα IP from cytosolic fractions pre-
cipitated both Catα and Catβ (Fig. S3, J and K). The mechanism 
conferring Catβ selectivity with AKAP1 is unclear as is any 
potential functional significance. Acute CCCP treatment (1 h) 
diminished both AKAP1-RIIα and AKAP1-Catβ coprecipita-
tion by ∼60–70% in HeLa (Fig.  3, D and E) and SH-SY5Y 
cells (Fig.  3, F and G), revealing PKA holoenzyme ejection 
from AKAP1, and Catβ is not selectively released from RIIα. 
The extent of PKA displacement from AKAP1 is consistent 
with our findings in depolarized isolated mitochondria (Fig. 3, 
A and B). Also, progressive PKA loss from AKAP1 is con-
sistent with gradual PINK1 enrichment and activation in the 
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Figure 1. Controlled targeting of PINK1 to the OMM induces robust mitochondrial fission independently of Parkin and calcium-calcineurin. (A and B) Mi-
tochondrial morphology and quantification for TOM20-stained SH-SY5Y cells transfected with WT or KD PINK1Δ110-YFP-FKBP/FRB-Fis1 and treated with 
rapalog for 0–2 h. (C and D) PINK1 protein level (adjusted for β-actin) in SH-SY5Y cells transfected with WT or KD PINK1Δ110-YFP-FKBP/FRB-Fis1. (E and 
F) Mitochondrial morphology and quantification for TOM20-stained PD-Parkin#1 primary human fibroblasts transfected with either WT or KD PINK1Δ110-
YFP-FKBP/FRB-Fis1, treated with rapalog for 0–2 h. (G and H) PINK1 level (adjusted for β-actin) in primary human PD-Parkin#1 fibroblasts transfected 
with WT or KD PINK1Δ110-YFP-FKBP/FRB-Fis1. (I) MFN1 ubiquitylation in two control primary human fibroblast cultures (C1 and C2) compared with 
PD-Parkin#1 after 2-h CCCP treatment. Bars: 15 µM; (insets) 5 µM. Each experiment was repeated at least three separate times and the error bars show 
the SDM. ***, P < 0.001.
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OMM of depolarized mitochondria (not an immediate reac-
tion to mΔΨ dissipation).
Does PINK1 disrupt the AKAP–PKA axis? To address 
this question, we silenced pink1 in SH-SY5Y cells, retarding 
MFN1 ubiquitylation and diminishing PINK1 accumulation 
after depolarization (Fig. S3, L and M). Complimentary ex-
periments were performed with PD-PINK1 fibroblasts (ex-
pressing Parkin) either devoid of PINK1 protein (PD-PINK1 
null) or comprising defective kinase activity (PD-PINK1 
KD [ILE368ASN]) in conjunction with control fibroblasts 
(expressing PINK1 and Parkin; Fig. S1, D and E). In pink1- 
silenced SH-SY5Y cells and both PD-PINK1 fibroblasts, the 
AKAP1–PKA axis maintained after CCCP treatment but was 
diminished by 65% and 75% in control silenced SH-SY5Y cells 
and control fibroblasts, respectively (Fig.  3, F–I; and Fig. S3 
N). We also confirmed that the introduction of WT PINK1 into 
PD-PINK1 null fibroblasts restored depolarization-induced dis-
sociation of RIIα from AKAP1 (Fig. 3, J and K; and Fig. S3 
O). Finally, we found WT PINK1Δ110-YFP-FKBP decreased 
RIIα-AKAP1 coprecipitation by ∼40–45% (transfection 
Figure 2. Mitochondrial depolarization does not trigger AKAP1 degradation or release from the OMM. (A and B) AKAP1, MFN1, and Prohibitin protein 
levels in 0–8 h depolarized SH-SY5Y or HeLa cells. Quantification was corrected for β-actin. (C) Citrate synthase activity adjusted for protein (BCA) after 
0–18-h CCCP treatment in SH-SY5Y cells expressing endogenous and overexpressed Parkin. (D and E) AKAP1, Prohibitin, and Cx4-II protein levels in 
Parkin-overexpressing SH-SY5Y cells incubated with CCCP for 18 h. Quantification was corrected for β-actin. (F and G) AKAP1, MFN1, and TOM20 
protein levels and quantification in mitochondria isolated from CCCP-treated SH-SY5Y cells. un, untreated. (H) Immunocytochemistry demonstrating AKAP1 
colocalization with TOM20 in SH-SY5Y cells during 0–4-h CCCP treatment. Pearson coefficients as follows: untreated = 0.84 ± 0.03; 1-h CCCP = 0.85 
± 0.02; 4-h CCCP = 0.83 ± 0.01. Bars, 20 µM. Each experiment was repeated at least three separate times, and error bars indicate SDM. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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efficiency of ∼30–40%) after rapalog treatment (Fig.  4, A 
and B), and this mode of fission activation was impaired in 
drp1-silenced cells (Fig. 4 C and D). The abundance of serine 
637 phosphorylated DRP1 was diminished in rapalog-treated 
WT PINK1Δ110-YFP-FKBP–expressing cells, whereas basal 
DRP1 and AKAP1 levels were unaffected (Fig.  4, E and F). 
Thereby, PINK1 kinase activity is necessary for PKA displace-
ment from AKAP1 and consequent DRP1-mediated fission fol-
lowing PINK1 accumulation in the OMM.
In addition to recruiting Parkin/autophagy receptors to 
damaged mitochondria, we reveal that PINK1 also comprises 
robust mitochondrial pro-fission activity and thereby can be 
considered a master mitophagic regulator to ensure efficient 
mitophagy by coordinating the segregation and ubiquitin/au-
tophagy receptor labeling of damaged organelles. By demon-
strating PINK1-dependent dissociation of the AKAP1–PKA 
axis, we provide a mechanistic rationale to explain how dam-
aged segments of the mitochondrial reticulum (Jin and Youle, 
Figure 3. PINK1 induces PKA displacement from AKAP1. (A and B) Effect of depolarization on AKAP1, PKA catalytic subunit β< and TOM20 protein 
levels in mitochondria isolated from HeLa cells. (C) AKAP1 IP from untreated HeLa cells and RIα, RIIα, Catβ, Catα, or RIIβ immunoblots. (D and E) AKAP1 
CoIP with the PKA subunits RIIα and Catβ in HeLa cells ± 1-h CCCP treatment. RIIα/Catβ abundance corrected for AKAP1 levels and normalized to 100% in 
untreated samples. (F and G) CoIP between AKAP1 and RIIα/Catβ ± 1-h CCCP in control and pink1-silenced SH-SY5Y cells. RIIα/Catβ levels were corrected 
for AKAP1 and normalized to untreated samples. (H and I) AKAP1-RIIα CoIP in control (C1), PD-PINK1 null, and PD-PINK1 KD (Fig. S3 Y) fibroblasts 
after 2-h CCCP treatment. RIIα levels were adjusted for AKAP1 and normalized to untreated samples. (J and K) AKAP1-RIIα CoIP from 2-h CCCP-treated 
PD-PINK1 null fibroblasts after no transfection or WT or KD (K219M) PINK1 transfection (72 h). RIIα levels are adjusted for AKAP1 and normalized to 
non-transfected samples. PINK1 expression levels are shown in Fig. S3 O. All experiments were repeated at least three times, and error bars show SDM. 
**, P < 0.01; ***, P < 0.001.
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2013) are selectively sensitized for DRP1-mediated fission 
during basal mitophagy, a fundamental process that occurs in 
cells and neurons (Bingol et al., 2014). In agreement, a recent 
study demonstrated the fission and mitophagy of individually 
damaged organelles in the axons of neurons (Ashrafi et al., 
2014) and further emphasizes that damage-induced mitochon-
drial fragmentation does not require global mitochondrial de-
polarization. Further investigation is required to establish how 
PINK1 disrupts the AKAP1–PKA axis. PINK1 might directly 
phosphorylate AKAP1–PKA or direct other pathways, such as 
phosphoubiquitin. The notion that OMM-bound PINK1 com-
prises additional activities/substrates unrelated to Parkin sig-
naling is an emerging concept (Lai et al., 2015), and a recent 
study has revealed PINK1-dependent phosphorylation of Rab 
GTPases (Lai et al., 2015).
Interestingly, previous studies have shown fundamental 
connectivity between PINK1 and PKA activities; overexpressed 
cytosolic PINK1 robustly augmented PKA-mediated signal-
ing and neuronal morphogenesis via an unknown mechanism 
(Dagda et al., 2014). Our findings thus further support the notion 
that PINK1 and PKA activities converge and PINK1 may oper-
ate as a PKA regulator. Although we propose that calcineurin is 
not the fission activator during basal PINK1 mitophagy, because 
released calcium will rapidly diffuse from damaged mitochon-
drial sections, the PKA–calcineurin axis exerts key regulatory 
control by governing the propensity of fission events and can be 
manipulated to confer either protection or increased susceptibil-
ity to apoptotic stimuli (Merrill et al., 2011; Dagda et al., 2011).
Previous studies have shown that the mitochondrial re-
ticulum undergoes random passive fission events (Twig et al., 
2008; in the absence of exogenous stimuli/agonists), presum-
ably because DRP1, which repeatedly cycles to the OMM and 
forms oligomeric spirals (Merrill et al., 2011), is not always 
phosphorylated by PKA (a function of OMM-PKA Kcat) and/
or phosphorylated DRP1 has a decreased propensity, but not 
complete inability, of forming fission-competent spirals which 
envelop the OMM (Merrill et al., 2011). We therefore envis-
age that PINK1-activated fission is not absolutely requisite for 
Figure 4. Controlled targeting of PINK1 to the OMM disrupts 
the AKAP1–PKA axis and drives fission via DRP1. (A and B) 
SH-SY5Y cells transfected with WT or KD PINK1Δ110-YFP-
FKBP/FRB-Fis1 (48 h) and treated with rapalog for 1 h. (A) 
AKAP1-RIIα CoIP. (B) RIIα abundance corrected for AKAP1 
and normalized to 100% in untreated samples. (C and D) 
SH-SY5Y cells 72 h drp1- or control-silenced and transfected 
with WT or KD PINK1Δ110-YFP-FKBP/FRB-Fis1 for 48 h. Mi-
tochondrial morphology (TOM20-stained) and quantification 
after 2-h rapalog treatment. (E and F) AKAP1, DRP1, and 
phospho–serine 637 DRP1 levels in SH-SY5Y cells express-
ing WT or KD PINK1Δ110-YFP-FKBP/FRB-Fis1 (48  h) with 
or without 2-h rapalog treatment. Phospho-DRP1 adjusted 
for DRP1/β-actin and AKAP1 for β-actin. Experiments were 
repeated at least three times, and error bars indicate SDM. 
Bars: 20 µM; (insets) 10 µM. **, P < 0.01; ***, P < 0.001.
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mitophagy (because DRP1 will eventually catalyze a successful 
fission event) but ensures the rapid and efficient segregation of 
damaged organelles so mitophagy can proceed quickly. Indeed, 
mitochondrial degradation has been shown to occur within 
10–20 min after depolarization (Ashrafi et al., 2014), which pre-
sumably limits the possible contagion of damage to surrounding 
healthy mitochondria. Furthermore, it is also worth noting that 
rates of passive fission diverge across different cell types and are 
notably slower in the soma of neurons and in neurons in vivo. 
Accordingly, the significance of PINK1-activated fission may 
vary in different tissues with a more prominent role in neurons.
It is interesting to consider Parkin phosphorylation by 
PINK1 accelerates mitophagy but is also not absolutely re-
quired, because phosphorylated ubiquitin forms a secondary 
mode to fully activate Parkin (Kondapalli et al., 2012; Shi-
ba-Fukushima et al., 2012; Koyano et al., 2014; Kane et al., 
2014; Wauer et al., 2015). Therefore phosphoubiquitin and 
passive fission may serve as a contingency pathway to ensure 
ubiquitin tagging and segregation of damaged mitochondria if 
the primary pathways fail. Finally, the reformation of fission 
proposed here has intriguing implications for the broader un-
derstanding of mitophagy and questions the relevance of calci-
um-driven reactions occurring during systemic depolarization 
by canonical mitophagy-activating methods; this level of dam-
age occurring in vivo is highly unlikely. It is also interesting to 
contemplate how calcium may affect and influence other prin-
ciple mitophagy pathways. Does calcium inadvertently affect 
PINK1 or OMM-Parkin activity or stability, or even modulate 
substrate specificity and associated binding proteins?
Materials and methods
Reagents and antibodies
All reagents and chemicals were purchased from Sigma-Aldrich un-
less otherwise stated. Antibodies were as follows: rabbit polyclonal 
anti-PKAβ catalytic (Catβ), mouse monoclonal anti–mouse PKAα 
catalytic (Catα), monoclonal anti-PKA IIα regulatory (RIIα), mouse 
monoclonal anti-PKAIα regulatory (RIα), mouse monoclonal anti- 
PKA IIβ regulatory (RIIβ), rabbit monoclonal anti-TOM20, mouse 
monoclonal anti-TOM20, mouse monoclonal anti-Parkin, (Santa Cruz 
Biotechnology, Inc.); mouse monoclonal anti-DRP1 (BD); rabbit poly-
clonal anti-PINK1, rabbit polyclonal anti-AKAP1 (Novus Biologicals); 
mouse monoclonal anti-PDH E1α (ProteinTech); mouse monoclonal 
anti-β-actin, mouse monoclonal anti-MFN1, (Abcam); mouse mono-
clonal anti-HA (Covance); rabbit polyclonal anti-phospho-637 DRP1, 
rabbit polyclonal anti-Prohibitin, rabbit monoclonal anti-LC3B, rabbit 
polyclonal anti-MEK1/2 (Cell Signaling Technology); complex IV 
subunit II was a gift from J.-W.  Taanman (University College Lon-
don, London, England, UK).
Cell culture and treatments
SH-SY5Y cells were cultured in DMEM/F12 (Thermo Fisher Scien-
tific) and HeLa/fibroblasts in DMEM Glutamax (Thermo Fisher Sci-
entific). Media was further supplemented with 10% FBS (Thermo 
Fisher Scientific), 1  mM pyruvate (Thermo Fisher Scientific), non-
essential amino acids (Thermo Fisher Scientific), and penicillin/
streptomycin (complete media). Cells were cultured in 37°C 5% 
CO2 humidified atmosphere.
SH-SY5Y and HeLa cells were incubated with 20  µM CCCP 
(Sigma-Aldrich) and fibroblasts with 40 µM. Rapalog (ClonTech) was 
used at 250 nM. All cells were harvested by trypsinization (Thermo 
Fisher Scientific) followed by the addition of complete media and cell 
pellets (1,500 g, 5 min, 4°C) were twice washed in ice-cold PBS and 
frozen as pellets at –80°C until required.
Human primary fibroblasts
Control lines 1 and 2 were cultured from a 52-yr-old male and a 70-yr-
old female, respectively. The PD-PINK1 null culture comprises a 
frameshift deletion in PINK1 (c.261_276del16;p.Try90Leufsx12; pro-
vided by J. Hardy, University College London, London, England, UK). 
PD-Parkin#1 were cultured from a 50-yr-old female and comprise exon 
2 and 3 deletion. PD-Parkin#2 were cultured from a 63-yr-old female 
and comprise exon 4 and 5 depletion. PD-PINK1 KD fibroblasts were 
acquired from the Coriell Biorepository (ND40066) and comprise a 
homogeneous ILE368ASN mutation cultured from a 64-yr-old male.
Statistical analysis
All data are expressed as the means ± SD of the mean (SDM). Statis-
tical significance was calculated using the Student’s t test on at least 
triplicate experiments comparing against control of the equivalent 
experimental condition. P < 0.05 was considered significant and is 
denoted with a single asterisk, whereas P < 0.01 and P < 0.001 are 
denoted with two and three asterisks, respectively.
SDS-PAGE and Western blot analysis
Unless otherwise stated, cell pellets were solubilized in PBS-1% Tri-
ton X-100 supplemented with EDTA-free protease/phosphatase inhib-
itors (Pierce; 15 min, 4°C) and clarified using a table-top centrifuge 
(13,500 rpm, 10 min, 4°C). DTT-reduced extracts were loaded equally 
for protein (BCA protein determination assay), separated using SDS-
PAGE (precast 4–12% gels, Novex; Thermo Fisher Scientific) and 
transferred (wet transfer) onto PDVF membranes (Amersham Hy-
bond, 0.45 µm; GE Healthcare). Membranes were blocked using 5% 
powdered milk-PBS 0.1% Tween 20 solution for at least 1  h (RT) 
and then incubated with primary antibody overnight (4°C) in block-
ing buffer, followed by 1:2,000 HRP-conjugated secondary antibodies 
(Dako) for 1 h (RT) in blocking buffer. ECL chemiluminescent sub-
strate (Thermo Fisher Scientific) was used to detect immunoreactive 
proteins on x-ray film.
Citrate synthase activity measurements
A total of 20 µg clarified PBS-1% Triton X-100 lysate was added to 
200 µM oxaloacetate, acetyl-CoA, and 5,5′-dithio-bis-(2-nitrobenzoic 
acid (DTNB) in 50  mM Tris, pH 8.0, and measurements were per-
formed in triplicate. The formation of TNB was monitored at 412 nm, 
and enzymatic rates were calculated during the steady state and cor-
rected for protein amount (using the BCA assay).
Immunocytochemistry
SH-SY5Y cells and fibroblasts were seeded at 3.5 × 106 on 22-mm 
glass coverslips in six-well plates. Cells were fixed in 4% paraformal-
dehyde in PBS for 20 min at RT, subsequently washed three times in 
PBS, and solubilized for 20 min in PBS-0.25% Triton X-100 at RT. 
Then, SH-SY5Y cells were blocked in PBS-10% goat serum for 1 h 
at RT and incubated with rabbit or mouse anti-TOM20 (1:1,000) in 
PBS at 4°C; when required, anti-AKAP1 (1:1,000, 0.25% Triton 
X-100 included) was included in the overnight incubation. For fi-
broblasts, the blocking was performed overnight at 4°C in 10% goat 
serum–PBS. Then, fibroblasts were incubated with rabbit anti-TOM20 
(1:300) in PBS for 90 min at RT. Coverslips were washed three times 
in PBS to terminate primary antibody incubation and then 1:500 anti– 
rabbit Alexa Fluor 594–conjugated secondary antibody (Thermo Fisher 
Scientific) was added in PBS for 1  h at RT. When necessary 1:500 
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anti–mouse Alexa Fluor 488–conjugated secondary antibody was in-
cluded. Images were acquired using an inverted confocal microscope 
(LSM 510; ZEI SS) and 63× oil-immersion objectives. Alexa Fluor 594 
was excited using the 543-nm laser line (HeNe laser) and fluorescence 
detected with a 560-nm long-pass filter. A 488-nm laser line (argon 
laser) excited the Alexa Fluor 488 with fluorescence measured between 
510 and 550 nm using the appropriate filter.
Mitochondrial morphology analysis
For all experiments, 30–50 cells in at least five different fields of view 
were analyzed per repeat. Mitochondria morphology (TOM20 immunos-
tained) was quantified as described earlier (Koopman et al., 2008) via 
ImageJ. In brief, background was subtracted from raw images, which 
were subsequently linearly contrast optimized, applied with a 7 × 7 “top 
hat” filter, subjected to a 2 × 3 median filter, and then thresholded to gen-
erate binary images. The circularity, mean length and mitochondrial par-
ticles per number of cells were used to determine morphological changes.
Transfections and silencing
HiPerFect (QIA GEN) was used to transfect a suspension of SH-SY5Y 
cells with 30 nM pink1/control siRNA, 10 nM drp1/control siRNA 
(SMA RTpool ON-TAR GETplus siRNA; GE Healthcare), or 10 nM 
akap1/control siRNA (Santa Cruz Biotechnology, Inc.). For drp1 si-
lencing, cells were seeded onto glass coverslips in six-well plates at 
3 × 106 for 72 h;after 24 h, cells were transfected with the regulated 
heterodimerization plasmids (provided by R.  Youle, National Insti-
tutes of Health, Bethesda, MD). akap1 was silenced in SH-SY5Y cells 
seeded onto glass coverslips in six-well plates at 2.5 × 106 (for immu-
nofluorescence) or into six-well plates at 4 × 106 (for immunoblot), 
for 72 h. The Neon system was used to transfect FRB-Fis1 and WT/
KD PINK1Δ110-YFP-FKBP or WT/KD (K219M) human PINK1 (as 
indicated in figures) via electroporation. 2.5 × 107 SH-SY5Y cells or fi-
broblasts were washed twice in PBS and resuspended in 50 µl buffer R 
with either 0.5 µg PINK1Δ110-YFP-FKBP and 0.15 µg FRB-Fis1 per 
5 × 106 cells, or 1 µg WT/KD PINK1. Transfections were performed 
according to manufacturers’ instructions. After 48-h expression, the 
cultures were incubated with 250 nM Rapalog or CCCP treatment for 
2 h before immunocytochemistry, IP, or immunoblot analysis.
The following siRNAs were used: AKAP1 (sc-40301; Santa Cruz 
Biotechnology, Inc.); control (sc-37007; Santa Cruz Biotechnology, 
Inc.); PINK1 (L-004030-00-0005; GE Healthcare); DRP1 (L-012092-
00-0005; GE Healthcare); control (D-001810-10-05; GE Healthcare).
Fluo-4 live-cell imaging
SH-SY5Y cells were seeded onto 22-mm glass coverslips in six-well 
plates, as described in the Immunocytochemistry section. Cells were 
loaded with Fluo-4 AM (Thermo Fisher Scientific) for 45 min in Hank’s 
balanced salt solution (BSS; including 0.0025% Pluronic F-68), at RT. 
Fluo-4 was excited using the 488-nm laser line (argon laser), using a 
confocal microscope and 63× oil-immersion objective. For time resolved 
calcium quantification, fields of view comprising 20–40 SH-SY5Y cells 
were selected and Z-projection was performed to obtain maximum flu-
orescent intensities. Each experiment was performed four times in total. 
Using ImageJ, the mean intensities were determined across the Z-stack 
and the backgrounds, encompassing extracellular regions were measured 
and subtracted. Data are presented as the percentage change from the 
initial measurement or fluorescent intensity (arbitrary units).
SH-SY5Y cells were loaded with 25 nM TMRM+ (Thermo Fisher 
Scientific). Loading was performed for 30 min in HBSS, at RT. TMRM+ 
was excited using the 543-nm laser line (HeNe laser) and emission mea-
sured using a 560-nm long-pass filter. Fields of view comprising 20–40 
cells were selected and Z-projection performed to obtain maximum 
fluorescence intensities. Experiments were repeated three times. Imag-
ing was performed using a confocal microscope and 63× oil-immersion 
objectives. Data are presented as fluorescent intensity (arbitrary units).
Rapalog and CCCP were added to 250 nM or 20 µM, respec-
tively, as indicated in figures and in HBSS comprising the equivalent 
concentration of fluorescent probe.
Mitochondrial isolation and cytosolic fraction preparation
SH-SY5Y or HeLa cells were cultured onto 9 × 10 cm2 plates for each 
treatment to ∼3.5 × 107 and 2.5 × 107, respectively. After treatment, 
cells were collected and stored as pellets at −80°C until required. 
Thawed pellets were resuspended in ice cold 250 mM sucrose, 1 mM 
EDTA, 10 mM Tris, pH 7.4 (HCl), isolation buffer supplemented with 
EDTA-free protease-phosphatase inhibitors, ruptured via mechanical 
homogenization (1,500 rpm, 20 strokes) and then pelleted (1,500 g, 10 
min, 4°C). Supernatants (comprising mitochondria) were collected and 
pellets rehomogenized (1,500 rpm, 20 strokes), subsequently clarified 
(at 1,500 g, 10 min, 4°C) and supernatants pooled. Mitochondria were 
pelleted at 11,800 g (12 min, 4°C, with supernatants corresponding to 
cytosolic fractions) twice washed in isolation buffer, and the final pel-
lets resuspended in 50 µl of isolation buffer for Western blot analysis.
CoIP
1,000 µg clarified PBS-0.5% Triton X-100 lysate (100 µl) from CCCP-
treated SH-SY5Y or HeLa cells, 300 µg (100 µl) from CCCP-treated 
human fibroblasts ± WT or KD PINK1 transfection, 400 µg (100 µl) 
from rapalog-treated WT/KD PINK1Δ110-YFP-FKBP transfected 
SH-SY5Y cells, or 700 µg (200 µl) of cytosolic fraction (in mitochon-
drial preparation buffer) was incubated with either (as indicated in fig-
ures) 1 µg anti-AKAP1, 0.2 µg anti-PKA RIIα, 0.2 µg anti-PKA RIIβ, 
0.4 µg anti-PKACα, or 0.4 µg anti-PKACβ for 2 h at 4°C with 30 µl 
of recombinant protein G agarose (Thermo Fisher Scientific), washed 
three times in lysis buffer (2,000 g, 2.5 min, 4°C), and eluted in 0.1 M 
glycine, pH 2.5 (50 µl; Thermo Fisher Scientific) with pH adjusted by 
1 M Tris (final volume 60 µl). Samples were reduced (DTT) and heated 
to 70°C for 10 min before separation by SDS-PAGE.
Online supplemental material
Fig. S1 shows PINK1 and Parkin expression in the cells used in this study 
as well as data showing mitochondrial polarization and cytosolic calcium 
levels are not affected by rapalog. Fig. S1 also includes mitochondrial 
morphology images and analysis for the second PD-Parkin fibroblast 
cultures that were transfected with the regulated heterodimerization 
plasmids with or without rapalog. Fig. S2 includes the data showing 
the relationship between AKAP1 protein level and mitochondrial 
morphology and shows that AKAP1 is not degraded in the primary 
human fibroblasts used in this study. Release of PKA from SH-SY5Y 
depolarized mitochondrial fractions is also included. Fig. S3 shows data 
mapping the composition of PKA bound to AKAP1. PINK1 silencing 
efficacy in SH-SY5Y cells is included as is the preservation of AKAP1–
PKA in PD-PINK1 KD fibroblasts. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201509003 /DC1.
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